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Equality of the Sexes:
Found in Translation
Male fruit flies (and humans) have half the number of
X chromosomes that females have, yet the expres-
sion of X-linked proteins in males is the same be-
cause of a sex-specific compensatory mechanism. In
this issue of Cell, Beckmann et al. (2005) report that
a unique two-stage translation silencing mechanism
thwarts synthesis of a male-specific transcription ac-
tivator in female flies, ensuring that gene dosage
compensation occurs only in males.
The evolution of sex has been accompanied by an un-
equal distribution of sex chromosomes in females and
males. Selection pressure to equalize the expression of
sex-linked genes has driven the evolution of gene dos-
age compensation mechanisms. Surprisingly, individual
species have evolved radically different solutions to the
same problem. In mammals, dosage compensation is
mediated by inactivation of one of the two X chromo-
somes in females (Meller and Kuroda, 2002); in the
worm C. elegans, it is mediated by partial inactivation
of both X chromosomes in hermaphrodites; and in the
fruit fly Drosophila melanogaster, compensation re-
quires hypertranscription of the single X chromosome
in males. In this issue of Cell, Beckmann et al. (2005)
provide convincing evidence for a two-stage transla-
tional silencing mechanism in fruit flies which ensures
that dosage compensation is limited to males.
In Drosophila, gene dosage compensation is medi-
ated by a heteromultimeric dosage compensation
complex (DCC) containing five proteins—male-specific
lethal (msl)-1, -2, and -3, maleless (mle), and males ab-
sent on the first (mof)—as well as two noncoding RNAs,
RNA on the X-1 and X-2 (roX1 and roX2). The DCC
binds to several dozen positions along the single X
chromosome in males then spreads so that it coats
nearly the entire chromosome. This process is thought
to “loosen” chromatin structure by mof-mediated acet-
ylation of histone H4 at lysine 16. In this way, the tran-
scription machinery gains access to the promoters of
X-linked genes resulting in hypertranscription of the
single male X chromosome. DCC formation is regulated
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cby a sex-specific pathway. In female flies, the DCC is
not formed due to absence of the essential msl-2 pro-
tein. Indeed, ectopic expression of msl-2 in females
leads to severe developmental and viability defects due
to global overexpression of X-linked genes. Expression
of the msl-2 gene is regulated by the master controller
of dosage compensation (and sex determination), Sex-
lethal (SXL), a female-specific protein standing atop
this hierarchy (Figure 1). Expression of functional SXL
is ensured in females and suppressed in males through
a pathway that directs preferential transcription from
sex-specific promoters and transduces the primary ge-
netic X:A (autosome) signal.
SXL is a multifunctional RNA binding protein that
lays an important role in several sex-specific regula-
ory events. SXL expression from a female-specific
arly promoter drives a positive feedback loop in which
XL directs splicing of its own RNA to produce the
unctional protein; the absence of SXL in males results
n expression of an inactive truncated protein. There-
fter, SXL binds to an intron in the 5#-untranslated re-
ion (UTR) of the msl-2 RNA in females, causing reten-
ion of the intron, which is spliced out in males.
ubsequent binding of SXL to poly(U) stretches in this
ntron and in the 3#-UTR of msl-2 RNA causes strong
epression of msl-2 translation in female flies (Bashaw
nd Baker, 1997; Kelley et al., 1997). Robust repression
f msl-2 translation requires occupancy of both SXL
inding sites, and mutation of either of these crucial
ites is lethal (Bashaw and Baker, 1997).
The nature of the cooperation between SXL proteins
ound to opposite ends of the msl-2 transcript has re-
ained mysterious. In an elegant series of experiments
escribed in this issue, Matthias Hentze and his col-
eagues have taken a major step toward answering this
uestion (Beckmann et al., 2005). Taking advantage of
cell-free translation system derived from Drosophila
mbryos that recapitulates the critical features of
ukaryotic mRNA translation, these investigators show
hat the SXL proteins bound to the 5#- and 3#-UTR use
ifferent and independent silencing mechanisms. SXL
ound to the 3#-UTR inhibits the stable association of
he 43S preinitiation complex with msl-2 RNA, a finding
onsistent with previous work (Gebauer et al., 2003). In
ontrast, SXL bound to the 5#-UTR acts on ribosomal
ubunits that bypass the earlier block, stalling the 43S
omplexes upstream of the SXL binding site and before
he initiator codon, AUG. Thus, SXL imposes a unique
wo-stage blockade of translation initiation, causing ro-
ust repression of msl-2 protein synthesis. The authors
escribe the inhibition as a “fail-safe” mechanism.
owever, this term actually understates the critical im-
ortance of the two-component, sequential blocking
ystem. Fail-safe implies that a failure of one compo-
ent does not result in failure of the system, usually
ue to the presence of a redundant or compensatory
echanism. In female flies, mutation of either of the
wo crucial SXL binding sites permits sufficient transla-
ion of msl-2 mRNA to cause lethality. Thus, the two-
tage regulation by SXL may be more appropriately
ermed “leak-proof,” which emphasizes the requisite,
ear-total repression ofmsl-2 translation. The evolution
f this stringent mechanism of dosage compensation is
onsistent with the concept, first proposed by Herman
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493Figure 1. The Gene Dosage Compensation Pathway of the Fruit Fly
The presence of two X chromosomes in female fruit flies signals
the expression of the SXL protein from an early promoter and initi-
ates the female-specific X chromosome transcription pathway
(left). Early expression of SXL is absent in male fruit flies, which
have only one X chromosome, resulting in activation of an alternate
hypertranscription pathway (right). Early SXL protein expression in
females directs late SXL mRNAs into a female splicing mode which
results in late SXL protein production and establishes a positive
feedback loop that ensures robust expression of active SXL (top).
In males, SXL RNA, in the absence of early SXL protein, is alterna-
tively spliced to generate inactive truncated SXL protein. In fe-
males, SXL binds to the 5#-UTR intron and causes its retention in
msl-2 RNA. Subsequently, SXL binds to sites in this 5#-UTR intron
and in the 3#-UTR, repressing translation of msl-2 RNA by a two-
stage mechanism (middle). In males, the absence of SXL allows
the synthesis of msl-2 protein, which initiates the formation of the
multimeric DCC that causes hypertranscription of the single X
chromosome (bottom).Muller, that small but global changes in expression of
X chromosome genes have major consequences, in-
cluding death of the organism (Muller, 1948).
Key questions remain to be answered regarding this
dual silencing mechanism. For example, how does SXL
bound to the 3#-UTR block recruitment of the 43S
preinitiation complex at the distant 5# end of the tran-
script? Long-range translational control may be facili-tated by “circularization” of mRNA mediated by protein/
mRNA interactions at the transcript termini such as
those between the 3#-located poly(A) binding protein
and the 5#-located initiation complex (Mazumder et al.,
2001). The repression ofmsl-2 by SXL bound to 3#-UTR
suggests a mechanism involving transcript closure.
However, the mechanism must differ, at least in its com-
ponents, because msl-2 inhibition is independent of the
presence of the mRNA poly(A) tail and 5#-cap (Gebauer
et al., 1999, 2003). Alternate mechanisms of transcript
closure not requiring a cap or poly(A) tail have been
described and may be operative here (Mazumder et al.,
2003). One could speculate that the unidentified co-
repressor that binds to SXL is bivalent and by interact-
ing with SXL bound to both UTRs, this co-repressor
closes themsl-2 transcript, bringing 3#-UTR bound SXL
into the vicinity of the initiation site. The authors sug-
gest an alternate mechanism involving SXL-dependent
clustering of msl-2 mRNA into large inactive ribo-
nucleoproteins. Also unknown is the molecular mecha-
nism by which 5#-UTR bound SXL blocks 43S scan-
ning. A steric “road-block” to 43S scanning is unlikely
given that 80S ribosome elongation is permitted. Possi-
bly, SXL interacts and interferes with a component of the
43S complex, such as eIF2, that is absent in 80S ribo-
somes.
Earlier studies of transcript-specific repression of
translation have established that 5#- or 3#-UTR bind-
ing proteins target individual steps of translation ini-
tiation (Gebauer and Hentze, 2004). Here, the dem-
onstration of a silencing mechanism that works at two
sequential steps of the initiation process represents a
new paradigm of translation control. No doubt future
experiments will seek multistep translation control
mechanisms in other mRNAs and in other organisms,
particularly in processes where repression must be ab-
solute.
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